Clinical Trial Update: ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating ATN-161 in combination with carboplatin for recurrent malignant glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• ATN-161
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED